10-19128279-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001142308.3(MALRD1):c.1002G>A(p.Arg334Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0701 in 1,233,156 control chromosomes in the GnomAD database, including 3,356 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.084 ( 657 hom., cov: 33)
Exomes 𝑓: 0.068 ( 2699 hom. )
Consequence
MALRD1
NM_001142308.3 synonymous
NM_001142308.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.892
Genes affected
MALRD1 (HGNC:24331): (MAM and LDL receptor class A domain containing 1) This gene encodes a conserved protein that features multiple MAM (meprin-A5-protein tyrosine phosphatase mu) and LDLR A2 (low density lipoprotein receptor A2) domains. Expression of this gene is enriched in the small intestine and is upregulated during differentiation of a human cell line that exhibits properties of intestinal epithelial cells. The encoded protein has been shown to modulate production of FGF19 in a human intestinal cell line and may regulate bile acid metabolism in the liver. A synergistic interaction between an allele of this gene and the APOE E4 allele is associated with an elevated risk of Alzheimer's disease in human patients. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 10-19128279-G-A is Benign according to our data. Variant chr10-19128279-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 768351.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.892 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.123 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0840 AC: 12774AN: 152044Hom.: 657 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
12774
AN:
152044
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0681 AC: 73627AN: 1080994Hom.: 2699 Cov.: 31 AF XY: 0.0676 AC XY: 34484AN XY: 510360 show subpopulations
GnomAD4 exome
AF:
AC:
73627
AN:
1080994
Hom.:
Cov.:
31
AF XY:
AC XY:
34484
AN XY:
510360
show subpopulations
African (AFR)
AF:
AC:
2971
AN:
23014
American (AMR)
AF:
AC:
577
AN:
8424
Ashkenazi Jewish (ASJ)
AF:
AC:
1166
AN:
14384
East Asian (EAS)
AF:
AC:
16
AN:
26498
South Asian (SAS)
AF:
AC:
377
AN:
19584
European-Finnish (FIN)
AF:
AC:
1904
AN:
21096
Middle Eastern (MID)
AF:
AC:
415
AN:
4540
European-Non Finnish (NFE)
AF:
AC:
63272
AN:
919624
Other (OTH)
AF:
AC:
2929
AN:
43830
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
3174
6348
9521
12695
15869
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0840 AC: 12785AN: 152162Hom.: 657 Cov.: 33 AF XY: 0.0844 AC XY: 6278AN XY: 74388 show subpopulations
GnomAD4 genome
AF:
AC:
12785
AN:
152162
Hom.:
Cov.:
33
AF XY:
AC XY:
6278
AN XY:
74388
show subpopulations
African (AFR)
AF:
AC:
5213
AN:
41532
American (AMR)
AF:
AC:
1137
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
255
AN:
3472
East Asian (EAS)
AF:
AC:
7
AN:
5186
South Asian (SAS)
AF:
AC:
88
AN:
4832
European-Finnish (FIN)
AF:
AC:
1092
AN:
10572
Middle Eastern (MID)
AF:
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4759
AN:
67980
Other (OTH)
AF:
AC:
176
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
582
1164
1745
2327
2909
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
68
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 19, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.